Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,845
Closed -$28.6K 3798
2024
Q3
$28.6K Buy
2,845
+440
+18% +$6.42K ﹤0.01% 3729
2024
Q2
$37.5K Buy
2,405
+265
+12% +$4.44K ﹤0.01% 3844
2024
Q1
$46.9K Sell
2,140
-18
-0.8% -$400 ﹤0.01% 3807
2023
Q4
$41.8K Sell
2,158
-450
-17% -$8.21K ﹤0.01% 3759
2023
Q3
$48.1K Buy
2,608
+5
+0.2% +$90 ﹤0.01% 3799
2023
Q2
$48K Buy
+2,603
New +$61.6K ﹤0.01% 3821

Other funds holding OPTN

Invesco's OPTN Position: Q4 2024 in Review

Invesco sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 2,845 shares — an estimated $28.6K sold.

Invesco first reported a position in OPTN in Q2 2023 and held it in 6 quarters. The position peaked at $48.1K in Q3 2023. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Invesco reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Invesco sold 2,845 OptiNose shares in Q4 2024, an estimated $28.6K.
  • Invesco first reported a position in OptiNose in Q2 2023 and held it in 6 quarters.
  • Invesco's OptiNose position peaked at $48.1K in Q3 2023.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Invesco's 13F filing for Q4 2024, filed 13 Feb 2025.